Cargando…
Why clinical translation cannot succeed without failure
The high rates of attrition that occur in drug development are widely regarded as problematic, but the failure of well-designed studies benefits both researchers and healthcare systems by, for example, generating evidence about disease theories and demonstrating the limits of proven drugs. A wider r...
Autores principales: | London, Alex John, Kimmelman, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657068/ https://www.ncbi.nlm.nih.gov/pubmed/26599839 http://dx.doi.org/10.7554/eLife.12844 |
Ejemplares similares
-
Predicting Harms and Benefits in Translational Trials: Ethics,
Evidence, and Uncertainty
por: Kimmelman, Jonathan, et al.
Publicado: (2011) -
The Reasons Why Physicians Succeed
Publicado: (1907) -
Why we need to report more than 'Data were Analyzed by t-tests or ANOVA'
por: Weissgerber, Tracey L, et al.
Publicado: (2018) -
Editorial: Long Term User Training and Preparation to Succeed in a Closed-Loop BCI Competition
por: Müller-Putz, Gernot R., et al.
Publicado: (2022) -
Why Cells and Viruses Cannot Survive without an ESCRT
por: Calistri, Arianna, et al.
Publicado: (2021)